VWM
CAI

Vermillion Wealth Management’s Caris Life Sciences CAI Stock Holding History

Vermillion Wealth Management’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.8K Buy
+1,000
New +$17.9K ﹤0.01% 955

Other funds holding CAI

ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
OW
Olistico Wealth Tulsa, Oklahoma $234M AUM 31.19% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Vermillion Wealth Management's CAI Position: Q2 2026 in Review

Vermillion Wealth Management opened a new position in Caris Life Sciences (CAI) in Q2 2026: 1,000 shares worth $17.8K. The stake represents ﹤0.01% of the portfolio and ranks #955 among its holdings.

16 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Vermillion Wealth Management held 1,000 shares of Caris Life Sciences worth $17.8K as of Q2 2026.
  • Caris Life Sciences was a new Vermillion Wealth Management position in Q2 2026.
  • Caris Life Sciences made up ﹤0.01% of Vermillion Wealth Management's portfolio in Q2 2026, its #955 holding.
  • 16 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.